594 related articles for article (PubMed ID: 28583367)
1. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
Hassanzadeh P; Atyabi F; Dinarvand R
Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
[TBL] [Abstract][Full Text] [Related]
2. Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine.
Hassanzadeh P; Atyabi F; Dinarvand R
J Control Release; 2018 Jun; 280():58-75. PubMed ID: 29723612
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
Dilnawaz F; Sahoo SK
Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
[TBL] [Abstract][Full Text] [Related]
4. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
5. Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
Hassanzadeh P
J Control Release; 2020 Dec; 328():112-126. PubMed ID: 32882269
[TBL] [Abstract][Full Text] [Related]
6. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
Sa P; Singh P; Dilnawaz F; Sahoo SK
Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
[TBL] [Abstract][Full Text] [Related]
7. Applications of nanotechnology in drug delivery to the central nervous system.
Saeedi M; Eslamifar M; Khezri K; Dizaj SM
Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
[TBL] [Abstract][Full Text] [Related]
8. Nanotheranostics, a future remedy of neurological disorders.
Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
[TBL] [Abstract][Full Text] [Related]
9. Theranostics Aspects of Various Nanoparticles in Veterinary Medicine.
Bai DP; Lin XY; Huang YF; Zhang XF
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352960
[TBL] [Abstract][Full Text] [Related]
10. Theranostical application of nanomedicine for treating central nervous system disorders.
Ran W; Xue X
Sci China Life Sci; 2018 Apr; 61(4):392-399. PubMed ID: 29675554
[TBL] [Abstract][Full Text] [Related]
11. Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders.
Sharma A; Manchanda R; Pottoo FH; Ashraf GM
Curr Drug Metab; 2021; 22(4):251-262. PubMed ID: 33234099
[TBL] [Abstract][Full Text] [Related]
12. Application of nanodiagnostics and nanotherapy to CNS diseases.
Zhang W; Wang W; Yu DX; Xiao Z; He Z
Nanomedicine (Lond); 2018 Sep; 13(18):2341-2371. PubMed ID: 30088440
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology-Inspired Extracellular Vesicles Theranostics for Diagnosis and Therapy of Central Nervous System Diseases.
Tian T; Qiao S; Tannous BA
ACS Appl Mater Interfaces; 2023 Jan; 15(1):182-199. PubMed ID: 35929960
[TBL] [Abstract][Full Text] [Related]
15. Nanohybrids - cancer theranostics for tiny tumor clusters.
Dhandapani R; Sethuraman S; Subramanian A
J Control Release; 2019 Apr; 299():21-30. PubMed ID: 30797000
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis.
Posadas I; Monteagudo S; Ceña V
Nanomedicine (Lond); 2016 Apr; 11(7):833-49. PubMed ID: 26980585
[TBL] [Abstract][Full Text] [Related]
17. Theranostic applications of nanoparticles in neurodegenerative disorders.
Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
[TBL] [Abstract][Full Text] [Related]
18. Application of Nanomedicine to the CNS Diseases.
Carradori D; Gaudin A; Brambilla D; Andrieux K
Int Rev Neurobiol; 2016; 130():73-113. PubMed ID: 27678175
[TBL] [Abstract][Full Text] [Related]
19. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery.
Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC
Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173
[TBL] [Abstract][Full Text] [Related]
20. Nanobiotechnology-based drug delivery to the central nervous system.
Jain KK
Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
